ANGELA MCLEMORE: Open Payments
NPI 1508522376 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 30 payments from 10 companies in 2025. Trend: 2023 $530 · 2024 $409 · 2025 $595
Food & beverage: $505Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $201 |
| Sage Therapeutics, LLC | 6 | $120 |
| Boston Scientific Corporation | 2 | $70 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $42 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $23 |
| MILLICENT US INC | 1 | $21 |
| CooperSurgical, Inc. | 1 | $16 |
Products named: ZURZUVAE, Veozah, GEMTESA, Solyx SIS System, ACCRUFER, Bulkamid - Bulkamid Urethral Bulking Pack 2mL (OUS), Qelbree, SLYND.
Industry payments across AL — which companies pay providers there.
